ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine
© 2022 S. Karger AG, Basel..
Coronavirus disease (COVID-19) vaccine can alter the body's immunological balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of the autoimmune diseases which have been rarely reported to appear post-COVID-19 vaccine. Herein, we report the case of a 47-year-old woman who developed acute renal failure few days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Corticosteroids along with azathioprine were used for the management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:147 |
|---|---|
| Enthalten in: |
Nephron - 147(2023), 2 vom: 02., Seite 103-107 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
El Hasbani, Georges [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ANCA-associated vasculitis |
|---|
| Anmerkungen: |
Date Completed 22.03.2023 Date Revised 16.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1159/000525562 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343702967 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343702967 | ||
| 003 | DE-627 | ||
| 005 | 20231226021051.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000525562 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM343702967 | ||
| 035 | |a (NLM)35850104 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a El Hasbani, Georges |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2023 | ||
| 500 | |a Date Revised 16.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 S. Karger AG, Basel. | ||
| 520 | |a Coronavirus disease (COVID-19) vaccine can alter the body's immunological balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of the autoimmune diseases which have been rarely reported to appear post-COVID-19 vaccine. Herein, we report the case of a 47-year-old woman who developed acute renal failure few days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Corticosteroids along with azathioprine were used for the management | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a ANCA-associated vasculitis | |
| 650 | 4 | |a Acute renal failure | |
| 650 | 4 | |a Autoimmunity | |
| 650 | 4 | |a Coronavirus disease | |
| 650 | 7 | |a BNT162 Vaccine |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Azathioprine |2 NLM | |
| 650 | 7 | |a MRK240IY2L |2 NLM | |
| 700 | 1 | |a Uthman, Imad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nephron |d 1964 |g 147(2023), 2 vom: 02., Seite 103-107 |w (DE-627)NLM000008427 |x 2235-3186 |7 nnns |
| 773 | 1 | 8 | |g volume:147 |g year:2023 |g number:2 |g day:02 |g pages:103-107 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000525562 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 147 |j 2023 |e 2 |b 02 |h 103-107 | ||